Citation Impact
Citing Papers
Incidence of inflammatory bowel disease in northern France (1988-1990).
1994
Imbalance of the interleukin 1 system in colonic mucosa—association with intestinal inflammation and interleukin 1 receptor agonist genotype 2
1997
Nod1 Detects a Unique Muropeptide from Gram-Negative Bacterial Peptidoglycan
2003 StandoutScience
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
2012 Standout
Innate and Adaptive Immunity Cooperate Flexibly to Maintain Host-Microbiota Mutualism
2009 StandoutScienceNobel
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study.
1990
Incidence of inflammatory bowel disease in north west Greece: rarity of Crohn's disease in an area where ulcerative colitis is common.
1994
Crohn's disease and colorectal cancer.
1994
Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years.
1990
Abnormal metabolism of arachidonic acid in chronic inflammatory bowel disease: enhanced release of leucotriene B4 from activated neutrophils.
1987
Mycobacterium avium subspecies paratuberculosis is a cause of Crohn's disease
2001
Inflammatory bowel disease and tobacco smoke--a case-control study.
1990
Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention.
1994
Crohn’s disease severity in familial and sporadic cases
1999
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
2001 Standout
Prognosis of colonic Crohn's disease.
1985
Bile acid transporters
2009
Ulcerative Colitis and Indeterminate Colitis in the City of Malmö, Sweden a 25-Year Incidence Study
1995
Prevalence of ulcerative colitis and Crohn’s disease in Japan
2009
A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease
2000
Low Mortality in Ulcerative Colitis and Crohn's Disease in Three Regional Centers in England
2001
The Risk of Colorectal Cancer in Ulcerative Colitis: An Epidemiologic Study
1987
The epidemiology and natural history of Crohn’s disease in population‐based patient cohorts from North America: a systematic review
2002
Cancer risk in patients with inflammatory bowel disease
2001 Standout
Infliximab Plus Azathioprine for Steroid-Dependent Crohn’s Disease Patients: A Randomized Placebo-Controlled Trial
2006
Overall and Cause-Specific Mortality in Ulcerative Colitis: Meta-analysis of Population-Based Inception Cohort Studies
2006
Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis
1995
Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease
2011
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
Health status in inflammatory bowel disease
1990
Management of Crohn's disease in adults
2001
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
2011 Standout
Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
1999 Standout
Ulcerative colitis in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival
2000
Efficacy of cyclosporine in treatment of fistula of crohn's disease
1994
Breastfeeding and genetic factors in the etiology of inflammatory bowel disease in children
2009
Gross Versus Microscopic Pancolitis and the Occurrence of Neoplasia in Ulcerative Colitis
2003
Crohn’s disease incidence evolution in North-western Greece is not associated with alteration of NOD2/CARD15 variants
2007
Increased risk of large-bowel cancer in Crohn's disease with colonic involvement
1990
Correlation between cyclical epithelial barrier dysfunction and bacterial translocation in the relapses of intestinal inflammation
2006
A Prospective Epidemiologic Study of Crohn's Disease in Heraklion, Crete Incidence over a 5-Year Period
1996
Do preoperative factors predict subsequent diagnosis of Crohn’s disease after ileal pouch‐anal anastomosis for ulcerative or indeterminate colitis?
2009
Epidemiology and outcome of Crohn’s disease in a teaching hospital in Riyadh
2004
Basic Epidemiology of Inflammatory Bowel Disease in Puerto Rico
2004
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
Meta-analysis of enteral nutrition as a primary treatment of active crohn's disease
1995
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Risk Factors for Surgery and Postoperative Recurrence in Crohn’s Disease
2000
Change in incidence of Crohn's disease and ulcerative colitis in Denmark. A study based on the National Registry of Patients, 1981-1992
1997
Azathioprine for maintenance of remission in Crohn's disease: Benefits outweigh the risk of lymphoma
2000
Update on the incidence and prevalence of Crohnʼs disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000
2006
Inflammatory bowel disease: epidemiology and management in an English general practice population
2000
Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986–2005: A KASID study
2007
AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease
2010
Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)
2008
Guidelines for the management of inflammatory bowel disease in adults
2011
Crohn's disease patients who quit smoking have a reduced risk of reoperation for recurrence
2004
Incidence and prevalence of ulcerative colitis in the Songpa‐Kangdong District, Seoul, Korea, 1986–1997
2000
Epidemiology of Crohn's Disease in Israel: A Survey of Israeli Kibbutz Settlements
1999
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Opposite evolution in incidence of Crohn’s disease and ulcerative colitis in Northern France (1988–1999)
2004
Ulcerative colitis—what is the risk of developing colorectal cancer?
1991
Oral tolerance and inflammatory bowel disease
2005
Epidemiology of Crohn's Disease and Ulcerative Colitis in a Central Canadian Province: A Population-based Study
1999
Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease
2003
Risk of Intestinal Cancer in Inflammatory Bowel Disease: A Population-Based Study From Olmsted County, Minnesota
2006
The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease
2002
Incidence of Crohn's Disease in Four Counties in Southeastern Norway, 1990–93 A Prospective Population-Based Study
1996
Influence of Phenotype at Diagnosis and of Other Potential Prognostic Factors on the Course of Inflammatory Bowel Disease
2009
Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort
1999
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
2001 StandoutNature
Treatment of severe Crohn's disease using antimycobacterial triple therapy — approaching a cure?
2002
Increasing Incidences of Inflammatory Bowel Disease and Decreasing Surgery Rates in Copenhagen City and County, 2003–2005: A Population-Based Study from the Danish Crohn Colitis Database
2006
A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
1997 Standout
Analysis of Australian Crohn's disease pedigrees refines the localization for susceptibility to inflammatory bowel disease on chromosome 16
1998
Ulcerative Colitis and Colorectal Cancer
1990 Standout
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
2001 Standout
Inflammatory bowel disease: cause and immunobiology
2007 Standout
Inflammatory bowel disease: The difference between children and adults
2008
Generation of regulatory gut-homing human T lymphocytes using ex vivo interleukin 10 gene transfer
2002
Inflammatory Bowel Disease
2009 Standout
Familial aggregation in Crohn's disease and ulcerative colitis in a Norwegian population-based cohort followed for ten years
2008
Incidence of Inflammatory Bowel Disease in Italy: A Nationwide Population-Based Study
1996
Has disease outcome in Crohn's disease changed during the last four decades?
2004
Clinical Course in Crohn’s Disease: Results of a Norwegian Population-Based Ten-Year Follow-Up Study
2007
Smoking cessation and the course of Crohn's disease: An intervention study
2001
Crohn's disease and cancer: A population-based cohort study
1994
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Age at onset of inflammatory bowel disease and the risk of surgery for non‐neoplastic bowel disease
2007
Clinical Outcome of Crohn's Disease: Analysis According to the Vienna Classification and Clinical Activity
2001
Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trends
2010
Mechanisms in failure of infliximab for Crohn's disease
2000
Predictors of Crohn’s Disease
2006
Prevalence of inflammatory bowel disease in two districts of Sri Lanka: a hospital based survey
2010
Course of ulcerative colitis: Analysis of changes in disease activity over years
1994
Inflammatory Bowel Disease
1991 Standout
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
2001 StandoutNature
A Simple Classification of Crohnʼs Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998
2000 Standout
Mapping of a susceptibility locus for Crohn's disease on chromosome 16
1996 Nature
Phenotype at diagnosis predicts recurrence rates in Crohn’s disease
2005
Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery
2005
Double-Blind Comparison of Slow-Release 5-Aminosalicylateand Sulfasalazine in Remission Maintenance in Ulcerative Colitis
1988
Ulcerative colitis
2012 Standout
Mesalamine in the treatment of mild to moderate active Crohn's ileitis: Results of a randomized, multicenter trial
1999
Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease
2004
Pathogenic Yersinia DNA Is Detected in Bowel and Mesenteric Lymph Nodes From Patients With Crohn's Disease
2003
Mycobacterium aviumsubsp.paratuberculosisas one cause of Crohn’s disease
2001
High incidence of Crohnʼs disease in Canterbury, New Zealand: Results of an epidemiologic study
2006
The Role of Microbes in Crohn's Disease
2006
Autophagy in the Pathogenesis of Disease
2008 Standout
Inflammatory Bowel Disease
2002 Standout
Plant pathogens and integrated defence responses to infection
2001 StandoutNature
Colorectal cancer in patients with ulcerative colitis
1988
A Placebo-Controlled, Double-Blind, Randomized Trial of Cyclosporine Therapy in Active Chronic Crohn's Disease
1989
Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis
1995
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
Epidemiology of inflammatory bowel disease
2002
Intestinal cancer risk and mortality in patients with Crohn's disease
1993
The Natural History of Pediatric Ulcerative Colitis: A Population-Based Cohort Study
2009
Thirty-Year Analysis of a Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis
2006
A Population-Based Study of Inflammatory Bowel Disease in Florence over 15 Years (1978-92)
1996
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
2002 Standout
Oral beclometasone dipropionate in the treatment of extensive and left‐sided active ulcerative colitis: a multicentre randomised study
2003
Polymeric Diet Alone Versus Corticosteroids in the Treatment of Active Pediatric Crohn’s Disease: A Randomized Controlled Open-Label Trial
2006
Small Bowel Adenocarcinoma in Patients with Crohnʼs Disease Compared with Small Bowel Adenocarcinoma De Novo
2005
Inflammatory Bowel Disease in South Limburg (the Netherlands) 1991–2002: Incidence, diagnostic delay, and seasonal variations in onset of symptoms
2009
Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics
2003
Anticipation in inflammatory bowel disease: A phenomenon caused by an accumulation of confounders
2000
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Inflammatory bowel disease in the Asia–Pacific area: A comparison with developed countries and regional differences
2010
Genetics in twins with Crohnʼs disease: Less pronounced than previously believed?
2010
Inflammation and cancer: back to Virchow?
2001 Standout
The pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro‐drugs used in the management of ulcerative colitis
2002
Ulcerative Proctocolitis in Örebro, Sweden: A Retrospective Epidemiologic Study, 1963–1987
1992
Mortality and causes of death in Crohn's disease: Follow-up of a population-based cohort in Copenhagen County, Denmark
2002
A Genomewide Analysis Provides Evidence for Novel Linkages in Inflammatory Bowel Disease in a Large European Cohort
1999
Long-term complications, extraintestinal manifestations, and mortality in adult Crohnʼs disease in population-based cohorts
2010
CROHN'S DISEASE IN THE HUNTER VALLEY REGION OF AUSTRALIA
1995
Predictors of hospitalization early in the course of Crohn's disease
1990
The Prevalence of Crohn’s Disease in Israel: A 20-Year Survey
2008
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Inflammatory Bowel Disease
1996
Crohn's disease: Pathogenesis and persistent measles virus infection
1995
A Comparison of Methotrexate with Placebo for the Maintenance of Remission in Crohn's Disease
2000
Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders
2013 Standout
Genetics and pathogenesis of inflammatory bowel disease
2011 StandoutNature
Survival and causes of death in patients with inflammatory bowel disease: A population-based study
1992
The Inflammasomes
2010 Standout
Oral pentasa in the treatment of active Crohn’s disease: A meta-analysis of double-blind, placebo-controlled trials
2004
Childhood Factors in Ulcerative Colitis and Crohn's Disease: An International Cooperative Study
1987
Clinical implications of mucosal healing for the management of IBD
2009
Ulcerative colitis and clinical course: Results of a 5-year population-based follow-up study (the IBSEN study)
2006
The Natural History of Adult Crohn's Disease in Population-Based Cohorts
2009
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
2004 Standout
Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978???2002
2006
High incidence of inflammatory bowel disease in The Netherlands
1998
Clinical patterns, natural history, and progression of ulcerative colitis
1993
Review article: altering the natural history of Crohn's disease – evidence for and against current therapies
2006
Small-area Variations and Sociodemographic Correlates for the Incidence of Crohn's Disease and Ulcerative Colitis
2001
Cancer in patients with ulcerative colitis
1995
Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease
1999
Crohn's Disease in the Singapore Chinese Population
1998
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
The Genetics of Inflammatory Bowel Disease
2007
Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients
2003
Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics
1997
Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts
2011
Malignancy in Ulcerative Colitis
1989
Genetic Epidemiology in Inflammatory Bowel Disease
1998
Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease
2003
Prior appendectomy and the phenotype and course of Crohn’s disease
2006
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Points of control in inflammation
2002 StandoutNature
Mucosal Healing in Crohnʼs Disease
2012
Efficacy and safety of retreatment with anti–tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease
1999
Systematic review: the effectiveness of budesonide therapy for Crohn's disease
2002
Epidemiology of inflammatory bowel disease in a German twin cohort: Results of a nationwide study
2008
Diversity, stability and resilience of the human gut microbiota
2012 StandoutNature
NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression
2004
Incidence of inflammatory bowel disease in Primorsko-goranska County, Croatia, 2000–2004: A prospective population-based study
2005
Epidemiology and clinical characteristics of ulcerative colitis in Chinese population: Experience from a single center in Hong Kong
2007
Risk factors and characteristics of extent progression in ulcerative colitis
2009
Time Trends in the Incidence and Disease Location of Crohnʼs Disease 1980-1995: A Prospective Analysis in an Urban Population in Germany
1999
Colorectal cancer risk and mortality in patients with ulcerative colitis
1992
Methotrexate for the Treatment of Crohn's Disease
1995
Diet and Inflammatory Bowel Disease: A Case-Control Study
1992
Quality of life: A valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease
1994
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
A Critical Review of Epidemiological Studies in Inflammatory Bowel Disease
2001
Regulation of Homeostasis and Inflammation in the Intestine
2011
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease
2006
Management of Crohn's Disease in Adults
2009 Standout
Budesonide for Maintenance of Remission in Patients with Crohn's Disease in Medically Induced Remission: A Predetermined Pooled Analysis of Four Randomized, Double-Blind, Placebo-Controlled Trials
2005
Prevalence of Crohn's Disease and Simultaneous Occurrence of Extraintestinal Complications and Cancer An Epidemiologic Study in Adults
1996
Mesalamine capsules for the treatment of active Crohn's disease: Results of a 16-week trial
1993
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease
2002
Crohn’s disease in Stockholm County during 1990-2001: An epidemiological update
2006
Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County
2003
Epidemiology of inflammatory bowel disease in adults who refer to gastroenterology care in Romania
2004
The limitations of corticosteroid therapy in Crohn’s disease
2001
Guidelines for the management of inflammatory bowel disease in adults
2004
The Epidemiology of Inflammatory Bowel Disease in Canada: A Population-Based Study
2006
Crohn's disease in Olmsted County, Minnesota, 1940–1993: Incidence, prevalence, and survival
1998
Long-term Follow-up of Ulcerative Colitis in the Chinese Population
2009
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
2000 StandoutNature
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study
2007
A Comparison of Budesonide and Mesalamine for Active Crohn's Disease
1998
Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn’s disease
2004
Incidence of ulcerative colitis in Cardiff over 20 years: 1968-87.
1992
Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD).
1996 Standout
Differentiating Ulcerative Colitis from Crohn Disease in Children and Young Adults: Report of a Working Group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America
2007
A simple classification of Crohn's disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998
2007
Incidence and Prevalence of Ulcerative Colitis and Crohn's Disease in the County of Copenhagen, 1962 to 1978
1982
Altered expression of mucins throughout the colon in ulcerative colitis.
1997
Influence of Phenotype at Diagnosis and of Other Potential Prognostic Factors on the Course of Inflammatory Bowel Disease
2009
Clinical Aspects and Pathophysiology of Inflammatory Bowel Disease
2002
Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres.
1988
Ulcerative Colitis and Crohn's Disease on the Faroe Islands 1964-83: A Retrospective Epidemiological Survey
1986
Are There Any Differences in Phenotype or Disease Course Between Familial and Sporadic Cases of Inflammatory Bowel Disease? Results of a Population-Based Follow-Up Study
2007
Intensive intravenous treatment of ulcerative colitis
1985
Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982.
1988
PSYCHOSOCIAL FACTORS IN INFLAMMATORY BOWEL DISEASE
1995
A New Measure of Health Status for Clinical Trials in Inflammatory Bowel Disease
1989
Colon Cancer, Dysplasia, and Surveillance in Patients with Ulcerative Colitis
1987
[Colorectal cancer in ulcerative colitis].
2014
Interactions Between the Microbiota and the Immune System
2012 StandoutScience
Double-blind, placebo-controlled evaluation of 5-ASA suppositories in active distal proctitis and measurement of extent of spread using99mTc-labeled 5-ASA suppositories
1987
Incidence, Clinical Presentation and Location at Diagnosis of Pediatric Inflammatory Bowel Disease: A Prospective Population‐Based Study in Northern France (1988‐1999)
2005
Incidence of Ulcerative Colitis and Indeterminate Colitis in Four Counties of Southeastern Norway, 1990–93 A Prospective Population-Based Study
1996
The costs of Crohn's disease in the United States and other Western countries: a systematic review
2007
[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
2007
Overall and cause-specific mortality in Crohnʼs disease: A meta-analysis of population-based studies
2009
Inflammatory bowel disease incidence: up, down or unchanged?
1998
Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract
2005 StandoutScience
Azodisal sodium in the treatment of ulcerative colitis
1986
Genetic markers in clinically well defined patients with ulcerative colitis (UC)
1999
Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern Norway.
1997
Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis.
1994
Growth Factors and Cancer
1991 StandoutScience
Delayed-Release Oral Mesalamine 4.8 g/day (800 mg tablets) Compared with 2.4 g/day (400 mg tablets) for the Treatment of Mildly to Moderately Active Ulcerative Colitis: The ASCEND I Trial
2007
Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: Evidence for epistasis between 1p and IBD1
1998
A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis
2006 Standout
Clinical patterns of familial inflammatory bowel disease.
1996
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
Incidence of Crohn’s disease in Stockholm County 1955–1989
1997
The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study
2008
Inflammatory bowel disease is associated with changes of enterocytic junctions
2001
Alterations of the Intestinal Barrier in Patients With Autism Spectrum Disorders and in Their First‐degree Relatives
2010
Alterations of the Immune System in Ulcerative Colitis and Crohn's Disease
1988
The Long-Term Stability of the Human Gut Microbiota
2013 StandoutScience
Effects of current and former cigarette smoking on the clinical course of Crohn’s disease
1999
Recent Developments in Nonspecific Inflammatory Bowel Disease
1982
Tacrolimus (FK506) for induction of remission in refractory ulcerative colitis
2008
A critical review of cyclosporine therapy in inflammatory bowel disease
1995
Psychosocial factors in inflammatory bowel disease.
1995
The Structure of Haplotype Blocks in the Human Genome
2002 StandoutScience
Prognosis of chronic ulcerative colitis in a community.
1987
Surveillance in ulcerative colitis: burdens and benefit.
1988
Familial Occurrence of Inflammatory Bowel Disease
1991
Works of V. Binder being referenced
Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives.
1994
Familial occurrence of complement dysfunction in Crohn's disease: correlation with intestinal symptoms and hypercatabolism of complement.
1985
Disodium cromoglycate in the treatment of ulcerative colitis and Crohn's disease.
1981
Life prospects and quality of life in patients with Crohn's disease.
1987
Leucocyte function in Crohn's disease. Studies on mobilisation using a quantitative skin window technique and on the function of circulating polymorphonuclear leucocytes in vitro.
1982
Long term prognosis in ulcerative colitis--based on results from a regional patient group from the county of Copenhagen.
1985
Social prognosis in patients with ulcerative colitis.
1980
Steady-State Kinetics of 5-Aminosalicylic Acid and Sulfapyridine during Sulfasalazine Prophylaxis in Ulcerative Colitis
1986
Familial occurrence and inheritance studies in inflammatory bowel disease
1996
Epidemiology in Gastroenterology
1996
Changes in Extent of Ulcerative Colitis A Study on the Course and Prognostic Factors
1996
Low‐dose cyclosporin for Crohn's disease: implications for clinical trials
1989
Prevalence of Hepatobiliary Dysfunction in a Regional Group of Patients with Chronic Inflammatory Bowel Disease
1991
5-Aminosalicylic Acid in the Treatment of Crohn's Disease: A 16-Week Double-Blind, Placebo-Controlled, Multicentre Study with Pentasa®
1987
Disease Activity Courses in a Regional Cohort of Crohn's Disease Patients
1995
Mycobacterium paratuberculosis in Intestinal Tissue from Patients with Crohn's Disease Demonstrated by a Nested Primer Polymerase Chain Reaction
1994
Incidence and Prevalence of Ulcerative Colitis in Copenhagen County from 1962 to 1987
1991
TNFSF15 Polymorphisms Are Associated With Susceptibility to Inflammatory Bowel Disease in a New European Cohort
2009
Incidence and Prevalence of Crohn's Disease in the County of Copenhagen, 1962-87: A Sixfold Increase in Incidence
1992
Final Report on a Placebo-Controlled, Double-Blind, Randomized, Multicentre Trial of Cyclosporin Treatment in Active Chronic Crohn's Disease
1991
Inflammatory Bowel Diseases with Onset in Childhood: Clinical Features, Morbidity, and Mortality in a Regional Cohort
1997
Intestinal and extra‐intestinal cancer in Crohn's disease: follow‐up of a population‐based cohort in Copenhagen County, Denmark
2004
Elemental diet: a therapeutic approach in chronic inflammatory bowel disease
1989
Granulomas of the Appendix: Is It Crohn's Disease?
1991
Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis.
1993
MUTATION SCREENING IN THE CD19 AND CD43 (SIALOPHORIN) GENES IN CROHN DISEASE PATIENTS
1999
Colonic epithelial dysplasia or carcinoma in a regional group of patients with ulcerative colitis of more than 15 years duration
1991
The Relapse-Preventing Effect of Methyl-Salazosulphapyridine Compared to Salazosulphapyridine during Long-Term Treatment of Ulcerative Colitis
1979
Bile Acid Metabolism in Patients with Crohn's Disease in Terminal Ileum
1986
5-Aminosalicylic Acid Enemas in Patients with Active Ulcerative Colitis
1984
[Long-term prognosis of patients with ulcerative colitis].
1993
Clinical Appearance at Diagnosis of Ulcerative Colitis and Crohn's Disease in a Regional Patient Group
1983
Prognosis in Crohn's disease--based on results from a regional patient group from the county of Copenhagen.
1985
Leucocyte function in ulcerative colitis. Quantitative leucocyte mobilisation to skin windows and in vitro function of blood leucocytes.
1982
Frequency of glucocorticoid resistance and dependency in Crohn's disease.
1994